Solitary Thyroid Nodule

61
SOLITARY THYROID NODULE Prepared by: Dr. Aisha M. Al-Zuhair Supervised by: Dr. Naif Awad KFHU – Khobar – Saudi Arabia Jan 20, 2010 1

Transcript of Solitary Thyroid Nodule

Page 1: Solitary Thyroid Nodule

1

SOLITARY THYROID NODULE

Prepared by: Dr. Aisha M. Al-Zuhair

Supervised by: Dr. Naif Awad

KFHU – Khobar – Saudi Arabia

Jan 20, 2010

Page 2: Solitary Thyroid Nodule

2

INTRODUCTION

Page 3: Solitary Thyroid Nodule

3

In the general population, thyroid nodules are discovered by palpation in 3% to 7%, and by US in 20% to 76%

More common in women than men Prevalence increases linearly with

age, exposure to ionizing radiation, and iodine deficiency

Hegedus L.:  Clinical practice: the thyroid nodule.  N Engl J Med 351. (17): 1764-1771.2004

Page 4: Solitary Thyroid Nodule

4

HISTORY AND PHYSICAL

Most patients present with an asymptomatic mass discovered by a physician on routine neck palpation or by the patient during self-examination.

Newly diagnosed thyroid nodules should be evaleuated primarily to role out malignancy.

Page 5: Solitary Thyroid Nodule

5

WHEN TO SUSPECT MALIGNANCY

Page 6: Solitary Thyroid Nodule

6

History of childhood head/neck irradiation

Family history of PTC, MTC, or MEN2 Age <20 or >70 yearsMale sexEnlarging noduleAbnormal cervical adenopathyFixed nodule

Gharib H - Endocrinol Metab Clin North Am - 01-SEP-2007; 36(3): 707-35, vi

Page 7: Solitary Thyroid Nodule

7

EXPOSURE TO RADIATION

The risk is maximum 20 to 30 years after exposure.

Most thyroid carcinomas following radiation exposure are papillary (PTC).

There is a 40% chance that patients presenting with a thyroid nodule and a history of radiation to have thyroid cancer.

Page 8: Solitary Thyroid Nodule

8

COMMON CAUSES OF THYROID NODULES

Page 9: Solitary Thyroid Nodule

9

BenignColloid noduleHashimoto’s thyroiditisSimple or hemorrhagic cystFollicular adenomaSubacute thyroiditis

Ross D.M.:  Diagnostic approach to and treatment of thyroid nodules. I.   In: Rose B.D., ed. UpToDateWellesley (MA)2005

Page 10: Solitary Thyroid Nodule

10

Malignant – PrimaryFollicular cell-derived carcinoma:PTC, FTC, anaplastic thyroid carcinoma

C-cell–derived carcinoma:MTCThyroid lymphoma

Malignant – SecondaryMetastatic carcinoma

Ross D.M.:  Diagnostic approach to and treatment of thyroid nodules. I.   In: Rose B.D., ed. UpToDateWellesley (MA)2005

Page 11: Solitary Thyroid Nodule

11

MANAGEMENT:DIAGNOSTIC WORKUP

Page 12: Solitary Thyroid Nodule

12

IMAGING

Page 13: Solitary Thyroid Nodule

13

ULTRASONOGRAPHY

Most sensitive test to detect lesions in the thyroid

It is recommended that all patients who have a nodular thyroid, with a palpable solitary nodule or a multinodular goiter,be evaluated by US

Not indicated as screening test in general population

Page 14: Solitary Thyroid Nodule

14

ULTRASONOGRAPHY

Indicated in:Palpable noduleHistory of radiation to the neckAge<20 & >70Family history of MTC, MEN2, or PTCPresence of cervical

lymphadenopathy

Page 15: Solitary Thyroid Nodule

15

US PREDICTION OF MALIGNANCY

Solitary versus multiple nodulesSizeExtracapsular growthComplex or cystic lesionsNodule shapeSuspicious cervical adenopathy

Page 16: Solitary Thyroid Nodule

16

SOLITARY VS MULTIPLE NODULES

The risk of cancer is not significantly higher for solitary nodules than for glands with several nodules

Page 17: Solitary Thyroid Nodule

17

SIZE

Cancer is not less frequent in small nodules (diameter <10 mm)

Page 18: Solitary Thyroid Nodule

18

EXTRACAPSULAR GROWTH Hypoechoic nodules with irregular

borders, Extension beyond the thyroid

capsule,Invasion into perithyroid muscles,

andInfiltration of the recurrent laryngeal

nerve Are sonographic features suggestive

of malignancy

Page 19: Solitary Thyroid Nodule

19

COMPLEX OR CYSTIC NODULE

Complex thyroid nodules have solid and cystic components.

These are often benign.Some PTCs may be cystic.

Page 20: Solitary Thyroid Nodule

20

NODULE SHAPE

 A rounded appearance A more tall than wide shape of

the nodule A marked hypoechogenicity of a

solid lesion are newly described US patterns

suggestive of malignancy 

Page 21: Solitary Thyroid Nodule

21

CERVICAL L.N.

Enlarged rounded cervical L.N.No hilusCystic changes MicrocalcificationChaotic hypervacularity

Page 22: Solitary Thyroid Nodule

22

ULTRASONOGRAPHY

The sensitivity of each feature is around 85%

The predictive value of these US features for cancer is in part diminished by their low sensitivity

No US sign by itself can reliably predict malignancy

Page 23: Solitary Thyroid Nodule

23

Gharib H - Endocrinol Metab Clin North Am - 01-SEP-2007; 36(3): 707-35, vi

Page 24: Solitary Thyroid Nodule

24Transverse ultrasonographic view of the right thyroid lobe showing a 1.2-cm hypoechoic nodule (N), which was benign by fine-needle aspiration biopsy. C, carotid artery; T, trachea.

Page 25: Solitary Thyroid Nodule

25

COLOR DOPPLER US

Evaluates nodule vascularity. Hypervascularity with chaotic

arrangement of blood vessels favors malignancy.

Peripheral flow indicates a benign nodule.

Page 26: Solitary Thyroid Nodule

26

US images of a left lobe thyroid nodule. (Lt) The 1.7 1.4-cm solid left lobe thyroid nodule was hypoechoic. (Rt) Color Doppler flow imaging shows hypervascularity. FNA biopsy showed papillary thyroid carcinoma, which was confirmed at surgery.

Page 27: Solitary Thyroid Nodule

27

OTHER IMAGING TECH

CT and MRI not as routine. Can asses size, retrosternal

extension, position and relation to the surrounding structure.

RAI scan: To differentiate hot from cold

nodulesMalignancy has been shown to occur

in 15% to 20% of cold nodules

Page 28: Solitary Thyroid Nodule

28

Images of a large, asymmetric multinodular goiter. (A) Chest radiography shows marked tracheal deviation to the right (arrow). (B) Chest CT confirmed the presence of a large substernal goiter on the left to the level of tracheal bifurcation.

Page 29: Solitary Thyroid Nodule

29

OTHER IMAGING TECHPET scan:

3-dimensional reconstruction imagesUse in detecting primary and

metastatic thyroid cancerThe clinical role of PET in pre-OP

investigation of thyroid nodules and in differentiating between benign and malignant lesions is controversial

Crippa F, Alessi A, Gerali A, et al: FDG-PET in thyroid cancer.  Tumori  2003; 89:540-543Urhan M - PET Clin - July, 2007; 2(3); 295-304.

Page 30: Solitary Thyroid Nodule

30

FNAC

Page 31: Solitary Thyroid Nodule

31

US GUIDED FNA

Indicated if:Palpation-guided FNA nondiagnosticComplex (solid/cystic) nodulePalpable small nodule (<1.5 cm)Impalpable noduleAbnormal cervical nodesNodule with suspicious US features

Page 32: Solitary Thyroid Nodule

32

FNAC SPECIMENS

70% Benign, 5% Malignant, 10% Suspicious, and 15% Unsatisfactory

Shwartz’s principles of surgery, 8th Ed

Page 33: Solitary Thyroid Nodule

33

FNAC RESULTS

Diagnostic / satisfactoryContains no less than six groups of

well-preserved thyroid epithelial cells consisting of at least 10 cells in each group

Nondiagnostic / unsatisfactoryInadequate number of cells result

from acellular cystic fluid, bloody smears, or poor techniques in preparing slides

Page 34: Solitary Thyroid Nodule

34(A) Benign (colloid) nodule. (B) Hashimoto thyroiditis. (C) Papillary thyroid carcinoma. (D) Unsatisfactory (nondiagnostic) smear. 

Page 35: Solitary Thyroid Nodule

35

BENIGN (-VE) CYTOLOGY

Most common findingIndicative of:

Colloid noduleMacrofollicular adenomaLymphocystic thyroiditisGranulomatus thyroiditis Benign cyst

Page 36: Solitary Thyroid Nodule

36

MALIGNANT (+VE) CYTOLOGY

Commonest is PTC:Increased cellularity, Tumor cells arranged in sheets and

papillary cell groupsTypical nuclear abnormalities, which

include intranuclear holes and grooves

Others include:MTC, anaplastic carcinoma, and

high-grade metastatic cancers

Page 37: Solitary Thyroid Nodule

37

SUSPECIOUS CYTOLOGY

Diagnosis cannot be madeInculdes:

Follicular neoplasms, Hürthle cell neoplasms, Atypical PTC, or Lymphoma

Page 38: Solitary Thyroid Nodule

38

SUSPECIOUS CYTOLOGY

Follicular neoplasms are most common:Hypercellular with microfollicular

arrangement and Decreased or absent colloid

Hürthle cell neoplasm: Almost exclusively Hürthle cellsAbsent or scanty colloid lacking a lymphoid cell population

Page 39: Solitary Thyroid Nodule

39

Gharib H - Endocrinol Metab Clin North Am - 01-SEP-2007; 36(3): 707-35, vi

Page 40: Solitary Thyroid Nodule

40

Occasionally associated with a minor hematoma

No serious adverse effect of the FNA

No seeding of tumor cells in the needle tract has been reported

Because of 5% false –ve, repeat of biopsy is recommended in some situations

Gharib H - Endocrinol Metab Clin North Am - 01-SEP-2007; 36(3): 707-35, vi

Page 41: Solitary Thyroid Nodule

41

INDICATIONS FOR REPEAT BIOPSY

Follow-up of benign noduleEnlarging noduleRecurrent cystNodule >4 cmInitial FNA nondiagnosticNo nodule shrinkage after T4

therapy

 Castro M.R., Gharib H.:  Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls.  Endocr Pract 9. (2): 128-136.2003

Page 42: Solitary Thyroid Nodule

42

TG OF FNA OF CERVICAL L.N.

Thyroglobulin (Tg) can be measured in lymph node or nodule aspirates.

FNA-Tg levels were markedly elevated in metastatic lymph nodes

 FNA-Tg sensitivity was 84.0%The combination of cytology plus

FNA-Tg increased FNA sensitivity from 76% to 92.0%.Gharib H - Endocrinol Metab Clin North Am - 01-SEP-2007; 36(3): 707-35, vi

Page 43: Solitary Thyroid Nodule

43

IMMUNOHISTOCHEMICAL MARKERSSeveral molecular markers and

assaysHBME-1

monoclonal antibody stains papillary cancer positively but

does not stain benign follicular tumors

Galectin-3acts as a cell-death suppressordistinguish benign from malignant

thyroid follicular tumors

Page 44: Solitary Thyroid Nodule

44

Despite most studies showing markers to have high sensitivity or specificity, no markers have high sensitivity and specificity for correctly diagnosing thyroid cancer

Bartolazzi A., Gasbarri A., Papotti M.Thyroid Cancer Study Group, et al:  Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions.  Lancet 357. (9269): 1644-1650.2001;  Segev D.L., Clark D.P., Zieger M.A., et al:  Beyond the suspicious thyroid fine needle aspirate: a review.  Acta Cytol 47. (5): 709-722.2003Castro M.R., Gharib H.:  Continuing controversies in the management of thyroid nodules.  Ann Intern Med 142. (11): 926-931.2005

Page 45: Solitary Thyroid Nodule

45

LABORATORY TEST

Page 46: Solitary Thyroid Nodule

46

TSH

To detect early or subtle thyroid dysfunction.

Inc in hashimoto thyroiditis and dec in subacute thyroiditis.

If TSH levels abnormal, free T3 & T4 should be measured to confirm the diagnosis.

American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.  Endocr Pract 12. (1): 63-102.2006

Page 47: Solitary Thyroid Nodule

47

TPOAB

Thyroid peroxidase antibodyMeasured in pt with high TSH.High levels of TPOab suggest

autoimmune disease – hashimoto thyroiditis

Page 48: Solitary Thyroid Nodule

48

SERUM TG

Correlates with iodine intake and the size of the thyroid gland rather than with the nature or function of the nodule

Seldom used in nodule diagnosis Extremely elevated levels of Tg

may suggest thyroid metastasis.

American Association of Clinical Endocrinologists. Endocr Pract 12. (1): 63-102.2006Schwartz's Principles of Surgery; 8ed

Page 49: Solitary Thyroid Nodule

49

SERUM CALCITONINGood marker for C-cell disease

and correlates well with tumor burden

Prevalence of MTC ranging from 0.4% to 1.4% in patients who have nodular thyroid disease

Routine calcitonin measurement in all patients who have a nodular thyroid has been recommended by European studiesElisei R., Bottici V., Luchetti F., et al:  Impact of routine measurement of serum

calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.  J Clin Endocrinol Metab 89. (1): 163-168.2004

Page 50: Solitary Thyroid Nodule

50

MANAGEMENT:TREATMENT

Page 51: Solitary Thyroid Nodule

51

Sabiston Textbook of Surgery, 18th ed

Page 52: Solitary Thyroid Nodule

52

FNAC +VE

Almost always surgical resectionIf malignancy is secondary,

further investigations needed to identify the primary

Page 53: Solitary Thyroid Nodule

53

THYROID OPERATIONS

Total thyroidectomy = 2 total lobectomy + isthemusectomy

Subtotal thyroidectomy =2 subtotal lobectomy +

isthemusectomyNear-total thyroidectomy =

Total lobectomy + subtotal lobectomy + isthemusectomy

Lobectomy Baily & love’s short practice of surgery; 24th ed

Page 54: Solitary Thyroid Nodule

54

SURGICAL MANAGEMENT

Lobectomy + isthemusectomy:In pt with low risk factors & Benign

nodulesNear-total or Total thyroidectomy:

In pt with high risk factors & Benign nodules

Malignant nodules

Gharib H - Endocrinol Metab Clin North Am - 01-SEP-2007; 36(3): 707-35, vi

Page 55: Solitary Thyroid Nodule

55

SURGICAL MANAGEMENT

Total thyroidectomy + cervical clearance:In MTCPTC and FTC with +ve L.N

Gharib H - Endocrinol Metab Clin North Am - 01-SEP-2007; 36(3): 707-35, vi

Page 56: Solitary Thyroid Nodule

56

FNAC -VE

Administration of T4 with TSH suppression:shrinking nodule size, arresting further nodule growth, and preventing the appearance of new

nodules 

Castro M.R., Caraballo P.J., Morris J.C.:  Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis.  J Clin Endocrinol Metab 87. (9): 4154-4159.2002

Page 57: Solitary Thyroid Nodule

57

FNAC -VE

T4 therapy not recommended for:As routine For postmenopausal womenpatients with cardiac diseaseLarge nodule or MNG TSH <0.5 mIU/mL

Gharib H - Endocrinol Metab Clin North Am - 01-SEP-2007; 36(3): 707-35, vi

Page 58: Solitary Thyroid Nodule

58

FNAC -VE

Most thyroid nodules do not need specific treatment if malignancy and abnormal thyroid function have been excluded

Clinical and US follow-up should be performed every 1 to 2 years.

Cooper D.S., Doherty G.M., Haugen B.R.The American Thyroid Association Guidelines Taskforce, et al:  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.  Thyroid 16. 109-142.2006

Page 59: Solitary Thyroid Nodule

59

FNAC nondiagnostic Cyst: aspirate and follow up 3

months Recurrent cyst: surgical Large cyst >3-4cm: surgicalBenign nodule: surgical

Gharib H - Endocrinol Metab Clin North Am - 01-SEP-2007; 36(3): 707-35, vi

Page 60: Solitary Thyroid Nodule

60

THANK YOU

Page 61: Solitary Thyroid Nodule

61

REFERENCES Shwartz’s principles of surgery, 8th Ed Sabiston text book of surgery, 18th Ed Baily & love’s short practice of surgery; 24th ed

Gharib H - Endocrinol Metab Clin North Am - 01-SEP-2007; 36(3): 707-35, vi Cooper D.S., Doherty G.M., Haugen B.R.The American Thyroid

Association Guidelines Taskforce, et al:  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.  Thyroid 16. 109-142.2006

Castro M.R., Caraballo P.J., Morris J.C.:  Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis.  J Clin Endocrinol Metab 87. (9): 4154-4159.2002

Elisei R., Bottici V., Luchetti F., et al:  Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.  J Clin Endocrinol Metab 89. (1): 163-168.2004

American Association of Clinical Endocrinologists. Endocr Pract 12. (1): 63-102.2006